SenesTech Inc (NASDAQ:SNES) shares were down 12.1% during mid-day trading on Thursday . The company traded as low as $1.50 and last traded at $1.52, approximately 829,367 shares were traded during trading. An increase of 210% from the average daily volume of 267,631 shares. The stock had previously closed at $1.73.

Separately, ValuEngine lowered shares of WideOpenWest from a “hold” rating to a “sell” rating in a research note on Friday, June 28th.

The stock has a market cap of $43.11 million, a P/E ratio of -2.41 and a beta of 1.77. The company’s 50 day moving average is $1.55. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.76 and a current ratio of 3.83.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.10). The company had revenue of $0.02 million for the quarter. SenesTech had a negative net margin of 3,908.08% and a negative return on equity of 186.65%. On average, equities research analysts predict that SenesTech Inc will post -0.19 earnings per share for the current year.

A hedge fund recently raised its stake in SenesTech stock. Virtu Financial LLC grew its position in shares of SenesTech Inc (NASDAQ:SNES) by 87.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 56,447 shares of the company’s stock after purchasing an additional 26,322 shares during the period. Virtu Financial LLC owned approximately 0.24% of SenesTech worth $69,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.73% of the company’s stock.

SenesTech Company Profile (NASDAQ:SNES)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

Further Reading: How dollar cost averaging works

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.